loading
Precedente Chiudi:
$1.27
Aprire:
$1.31
Volume 24 ore:
1.20M
Relative Volume:
2.91
Capitalizzazione di mercato:
$92.37M
Reddito:
-
Utile/perdita netta:
$-64.86M
Rapporto P/E:
-1.3661
EPS:
-1.12
Flusso di cassa netto:
$-55.66M
1 W Prestazione:
+14.77%
1M Prestazione:
+0.33%
6M Prestazione:
+27.31%
1 anno Prestazione:
-35.26%
Intervallo 1D:
Value
$1.30
$1.55
Intervallo di 1 settimana:
Value
$1.22
$1.55
Portata 52W:
Value
$0.8551
$3.36

Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile

Name
Nome
Acumen Pharmaceuticals Inc
Name
Telefono
617-344-4190
Name
Indirizzo
1210-1220 WASHINGTON STREET, NEWTON
Name
Dipendente
52
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
ABOS's Discussions on Twitter

Confronta ABOS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ABOS
Acumen Pharmaceuticals Inc
1.525 76.93M 0 -64.86M -55.66M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.14 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.37 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
553.69 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
709.92 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.85 36.23B 3.81B -644.79M -669.77M -6.24

Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-17 Iniziato Citigroup Buy
2024-07-26 Iniziato Citigroup Buy
2023-12-12 Iniziato Deutsche Bank Buy
2023-07-20 Ripresa BofA Securities Buy
2023-05-18 Iniziato Cantor Fitzgerald Overweight
2022-07-15 Iniziato BTIG Research Buy
2022-06-30 Iniziato H.C. Wainwright Buy
2022-01-21 Aggiornamento BofA Securities Neutral → Buy
2021-07-26 Iniziato BofA Securities Neutral
2021-07-26 Iniziato Credit Suisse Outperform
2021-07-26 Iniziato Stifel Buy
2021-07-26 Iniziato UBS Buy
Mostra tutto

Acumen Pharmaceuticals Inc Borsa (ABOS) Ultime notizie

pulisher
Sep 24, 2025

Trend analysis for Acumen Pharmaceuticals Inc. this week2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com

Sep 24, 2025
pulisher
Sep 24, 2025

Chart based analysis of Acumen Pharmaceuticals Inc. trendsJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com

Sep 24, 2025
pulisher
Sep 22, 2025

Institutional scanner results for Acumen Pharmaceuticals Inc.July 2025 Momentum & AI Enhanced Execution Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is it time to cut losses on Acumen Pharmaceuticals Inc.2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Analyzing net buyer seller activity in Acumen Pharmaceuticals Inc.Fed Meeting & Proven Capital Preservation Methods - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Acumen Pharmaceuticals, Inc.(NasdaqGS: ABOS) dropped from S&P Global BMI Index - MarketScreener

Sep 21, 2025
pulisher
Sep 21, 2025

Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth - MSN

Sep 21, 2025
pulisher
Sep 21, 2025

How to integrate Acumen Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Can technical indicators confirm Acumen Pharmaceuticals Inc.’s reversalSwing Trade & Weekly Hot Stock Watchlists - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Quantitative breakdown of Acumen Pharmaceuticals Inc. recent moveJuly 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Real time pattern detection on Acumen Pharmaceuticals Inc. stockJuly 2025 Movers & High Conviction Trade Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Is it too late to sell Acumen Pharmaceuticals Inc.July 2025 Catalysts & Consistent Income Trade Recommendations - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

What data driven models say about Acumen Pharmaceuticals Inc.’s futureIPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Is a relief rally coming for Acumen Pharmaceuticals Inc. holdersWeekly Earnings Recap & Low Risk Investment Opportunities - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Detecting support and resistance levels for Acumen Pharmaceuticals Inc.Dividend Hike & AI Driven Stock Reports - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Insider Buy: Should I hold or sell Acumen Pharmaceuticals Inc. nowMarket Movers & Safe Entry Point Identification - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Treasury Yields: How does Acumen Pharmaceuticals Inc. compare to its peersJuly 2025 PreEarnings & Low Volatility Stock Suggestions - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Should I hold or sell Acumen Pharmaceuticals Inc nowWeekly Trade Recap & Expert Curated Trade Ideas - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Breakouts: What’s the fair value of Ooma Inc. stockLayoff News & Technical Confirmation Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Real time scanner hits for Acumen Pharmaceuticals Inc. explainedEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Sentiment Watch: Will Acumen Pharmaceuticals Inc benefit from rate cutsJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Published on: 2025-09-17 00:11:41 - newser.com

Sep 17, 2025
pulisher
Sep 16, 2025

What is the earnings history of Acumen Pharmaceuticals IncJuly 2025 EndofMonth & Momentum Based Trading Ideas - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Acumen Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

What hedge funds are buying Acumen Pharmaceuticals IncJuly 2025 Drop Watch & Verified High Yield Trade Plans - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Activity Recap: Is Acumen Pharmaceuticals Inc. exposed to political risk2025 Sector Review & Low Drawdown Trading Techniques - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Profit Review: Is Acumen Pharmaceuticals Inc a cyclical or defensive stockJuly 2025 Decliners & Expert Verified Movement Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Published on: 2025-09-15 23:49:04 - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Sentiment Watch: What’s next for Acumen Pharmaceuticals Inc. stockWeekly Profit Recap & Free Fast Entry Momentum Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Fund Flows: Will Acumen Pharmaceuticals Inc. benefit from seasonality2025 Major Catalysts & Fast Moving Trade Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Take Profit: Is Acumen Pharmaceuticals Inc a strong candidate for buy and hold - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

How to read the order book for Acumen Pharmaceuticals Inc.2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Technicals: Is Acumen Pharmaceuticals Inc being accumulated by smart moneyJuly 2025 Fed Impact & AI Enhanced Trading Signals - خودرو بانک

Sep 15, 2025

Acumen Pharmaceuticals Inc Azioni (ABOS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Acumen Pharmaceuticals Inc Azioni (ABOS) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Zuga Matt
CFO & Chief Business Officer
Jan 21 '25
Sale
1.60
4,364
6,986
260,646
OConnell Daniel Joseph
Chief Executive Officer
Jan 21 '25
Sale
1.59
12,619
20,102
667,488
Meisner Derek M
Chief Legal Officer & Corp Sec
Jan 21 '25
Sale
1.59
3,418
5,435
161,127
Barton Russell
Chief Operating Officer
Jan 21 '25
Sale
1.61
2,914
4,692
136,117
Siemers Eric
Chief Medical Officer
Jan 21 '25
Sale
1.59
3,219
5,118
170,298
$20.33
price down icon 0.88%
$81.12
price down icon 3.56%
$28.89
price down icon 1.99%
$98.30
price down icon 1.44%
$135.67
price down icon 3.61%
biotechnology ONC
$328.54
price down icon 0.43%
Capitalizzazione:     |  Volume (24 ore):